Find Federal Grants
Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01- Clinical Trial Optional)
National Institutes of Health · RFA-DK-17-025
Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional)
National Institutes of Health · RFA-DA-19-003
Elucidating the Effect of Glycemic Excursions on Patient Well-being and Cognitive Status in People with Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DK-18-003
Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-17-021
High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-17-022
The Characterization and Discovery of Novel Autoantigens and Epitopes in Type 1 Diabetes (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DK-17-031
Health Resources and Services Administration · HRSA-18-096
Clinical Validation of Candidate Biomarkers for Neurological Diseases (U01 Clinical Trial Optional)
National Institutes of Health · PAR-18-664
Limited Competition: FaceBase 3: Craniofacial Development and Dysmorphology Data Management and Integration Hub (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DE-19-003
Incorporating Patient-Reported Outcomes into Clinical Care for Type 1 Diabetes (R01 Clinical Trial Required)
National Institutes of Health · RFA-DK-17-027
Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical Trial Optional)
National Institutes of Health · RFA-DK-17-032
Career Development Programs in Diabetes Research for Endocrinologists (K12 Clinical Trial Optional)
National Institutes of Health · RFA-DK-17-026
Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Required)
National Institutes of Health · RFA-DK-17-028
Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-17-020
Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes Research (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-17-019
National Institutes of Health · PA-18-660
Towards Implementing Novel Training Methods to Enhance Cognition in Aging (U01 Clinical Trial Required)
National Institutes of Health · RFA-AG-18-031
National Institutes of Health · RFA-HD-19-004
National Institutes of Health · PAR-18-659
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies Toward Commercialization (R44 Clinical Trial Optional)
National Institutes of Health · RFA-CA-18-011